Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers

Condition: Clear Renal Cell Cancer (< 7cm Size)

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT03694912

Sponsor: Yonsei University



  • Age: minimum 20 Years maximum N/A
  • Gender: All

Inclusion Criteria:

  • Patients diagnosed as clear cell renal cell caner T1 stage
  • Patients who have undergone partial or radical nephrectomy in Severance Hospital, Sinchon from 2018.11 and 2019.10
  • Those who agree to give permission to use their human source information
  • Those who agree with this study

Exclusion Criteria:

  • Vulnerable Participants
  • Those who don't agree with this study

View trial on